Drug resistance mechanism of PncA in Mycobacterium tuberculosis.
about
Role of ELA region in auto-activation of mutant KIT receptor: a molecular dynamics simulation insightCancer associated E17K mutation causes rapid conformational drift in AKT1 pleckstrin homology (PH) domainStructure-activity relationships study of mTOR kinase inhibition using QSAR and structure-based drug design approachesMutational analysis of FUS gene and its structural and functional role in amyotrophic lateral sclerosis 6.Bioinformatic Analysis of GJB2 Gene Missense Mutations.Simulation based investigation of deleterious nsSNP's in ATXN2 gene and its structural consequence towards Spinocerebellar Ataxia.Evidence of colorectal cancer-associated mutation in MCAK: a computational report.Identification of novel leads applying in silico studies for Mycobacterium multidrug resistant (MMR) protein.Molecular dynamic simulation reveals damaging impact of RAC1 F28L mutation in the switch I region.Identification and analysis of driver missense mutations using rotation forest with feature selection.Use of long term molecular dynamics simulation in predicting cancer associated SNPs.Mechanistic analysis elucidating the relationship between Lys96 mutation in Mycobacterium tuberculosis pyrazinamidase enzyme and pyrazinamide susceptibility.The expression and significance of Gal-3 and MUC1 in colorectal cancer and colon cancer.Structure-based design of novel naproxen derivatives targeting monomeric nucleoprotein of Influenza A virus.A Comprehensive In Silico Analysis on the Structural and Functional Impact of SNPs in the Congenital Heart Defects Associated with NKX2-5 Gene-A Molecular Dynamic Simulation Approach.Structure-based design of selective phosphodiesterase 4B inhibitors based on ginger phenolic compounds.Combination of cetuximab and PP242 synergistically suppress the progression of wild-type KRAS colorectal carcinoma.In silico screening and molecular dynamics simulation of disease-associated nsSNP in TYRP1 gene and its structural consequences in OCA3.Multicenter Study of the Emergence and Genetic Characteristics of Pyrazinamide-Resistant Tuberculosis in ChinaCandidate SNP Markers of Chronopathologies Are Predicted by a Significant Change in the Affinity of TATA-Binding Protein for Human Gene Promoters.Computational SNP analysis: current approaches and future prospects.Resistance in tuberculosis: what do we know and where can we go?Identification of novel natural inhibitor for NorM - a multidrug and toxic compound extrusion transporter - an insilico molecular modeling and simulation studies.Discovery of Potent ALK Inhibitors Using Pharmacophore-Informatics Strategy.In Silico Template Selection of Short Antimicrobial Peptide Viscotoxin for Improving Its Antimicrobial Efficiency in Development of Potential Therapeutic Drugs.Exploration of Structural and Functional Variations Owing to Point Mutations in α-NAGA.Non-active site mutations disturb the loop dynamics, dimerization, viral budding and egress of VP40 of the Ebola virus.Biochemical Characterization and Computational Identification of Mycobacterium tuberculosis Pyrazinamidase in Some Pyrazinamide-Resistant Isolates of Iran.Identifying novel oncogenes: a machine learning approach.Single Active Site Mutation Causes Serious Resistance of HIV Reverse Transcriptase to Lamivudine: Insight from Multiple Molecular Dynamics Simulations.Structure-function correlation analysis of connexin50 missense mutations causing congenital cataract: electrostatic potential alteration could determine intracellular trafficking fate of mutants.Comparative study of the efficacy of pulsed electromagnetic field and low level laser therapy on mitogen-activated protein kinases.Computational investigation of molecular mechanism and neuropathological implications in Huntington disease.Biophysical Aspect of Huntingtin Protein During polyQ: An In Silico Insight.MicroRNA-128 suppresses paclitaxel-resistant lung cancer by inhibiting MUC1-C and BMI-1 in cancer stem cells.Cysteine to Serine Conversion at 111th Position Renders the Disaggregation and Retains the Stabilization of Detrimental SOD1 A4V Mutant Against Amyotrophic Lateral Sclerosis in Human-A Discrete Molecular Dynamics Study.Deciphering the Molecular Effects of Mutations on ATRX Cause ATRX Syndrome: A Molecular Dynamics Study.Computational investigation of the human SOD1 mutant, Cys146Arg, that directs familial amyotrophic lateral sclerosis.Relationship between a point mutation S97C in CK1δ protein and its affect on ATP-binding affinity.Pathological role of a point mutation (T315I) in BCR-ABL1 protein-A computational insight.
P2860
Q28293108-8DFEDD92-97A1-4051-A463-878A3756BFC7Q28533515-DDB6929D-DB06-480C-9458-F0515C7EFB16Q28817760-32FCCC2F-428E-4D23-84E2-BEB0ED699A1EQ30361415-D925F8DA-13E8-404B-AC70-C3E096B126B3Q30368572-658C0D6C-89BD-4895-BBA4-CB8DE091B068Q30403031-58A88C5F-4DBE-47A4-87AC-EB910DC676F5Q30429097-29EC97CD-8F7F-4CAE-92E1-B1F8603BF1EEQ31141792-B14D0639-780E-4672-A3A7-E2CE24347E3CQ31142215-3EA2F78E-D384-4455-9E90-3E9FA52AE10CQ34177518-6FA63C34-D6A6-408D-B874-C1EFCF9F483CQ35144962-BFD84A1B-0982-452D-A483-164C80EE75DDQ35566384-17139566-677D-4102-9063-5CFBEDA58C19Q35915348-B900818B-F436-481D-BDA0-691A6E93FC2AQ35993057-CD876174-C619-430B-B459-53C30464076AQ36010644-67DF17A9-994A-4BE3-9C22-ED27F3885788Q36127167-1CD1BD4E-887C-4B5D-B168-A2A0D6D26F27Q36257068-71855B4C-6A73-4A96-9A4D-987BE5FEE970Q36990096-A7ABAC38-7A4B-4312-B25C-4CAA6E967E08Q37203722-67E78604-53A6-423A-9ED2-2BC879AC6F75Q37231785-02CCACC5-DE63-4AD6-84E2-DAAF6E6ED5DCQ38121517-E515C87F-827E-4829-A314-F0148EA81295Q38124261-339B0D0F-FDAE-40EB-8CDF-2D13B51A1989Q38383492-73F79173-CE06-4AB5-B355-449FC5EACCE1Q38687108-7EB5F04B-E610-4C40-A62B-AA044DB603C9Q38815427-4A244FED-2782-4799-918B-4A1488E8E879Q38872480-D5D972AD-BCD0-4A9B-8F2F-3D9A9B7DB122Q38974306-AB542839-B316-4D53-8670-586CFE9113F7Q38977310-BECA9578-D4DB-44EE-AE28-3C67C299A5DBQ39276893-852F708F-9431-4567-90E9-D55DC5BEF28EQ40856431-EEE07552-90D1-4C35-9612-6942F5CFD2F6Q40998290-CA738037-B4F4-4C90-BFE9-B2DAEAE95C18Q41682343-C811C19B-9929-4BEF-B13F-BB73D01CE679Q45290023-CAB23703-938C-452C-8132-95F595271673Q45294564-054AD597-964B-46AD-AEE2-D5B8C8BEDFC6Q47202039-1F6C7CCA-9C27-45B1-A764-5FF8443426E5Q47738138-D37D87A6-BAB6-45A7-AF85-99AF75CF264DQ47775756-D6914A02-477F-4BAC-8F9C-0C3218BF57E4Q48059574-BC17B4F0-4C1A-4A32-A337-07E004A22AB9Q48111017-21553FA1-4904-4D76-AAC2-74509BA0967CQ48168059-972C3DEA-84EA-42C8-A781-5F3271E7E359
P2860
Drug resistance mechanism of PncA in Mycobacterium tuberculosis.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Drug resistance mechanism of PncA in Mycobacterium tuberculosis.
@en
Drug resistance mechanism of PncA in Mycobacterium tuberculosis.
@nl
type
label
Drug resistance mechanism of PncA in Mycobacterium tuberculosis.
@en
Drug resistance mechanism of PncA in Mycobacterium tuberculosis.
@nl
prefLabel
Drug resistance mechanism of PncA in Mycobacterium tuberculosis.
@en
Drug resistance mechanism of PncA in Mycobacterium tuberculosis.
@nl
P2860
P1476
Drug resistance mechanism of PncA in Mycobacterium tuberculosis.
@en
P2093
Rao Sethumadhavan
Vidya Rajendran
P2860
P304
P356
10.1080/07391102.2012.759885
P577
2013-02-06T00:00:00Z